These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21912164)

  • 1. Growth outcomes in individuals with idiopathic short stature treated with growth hormone therapy.
    Dahlgren J
    Horm Res Paediatr; 2011; 76 Suppl 3():42-5. PubMed ID: 21912164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
    Albertsson-Wikland K; Aronson AS; Gustafsson J; Hagenäs L; Ivarsson SA; Jonsson B; Kriström B; Marcus C; Nilsson KO; Ritzén EM; Tuvemo T; Westphal O; Aman J
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4342-50. PubMed ID: 18728172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of growth hormone treatment on height in children with idiopathic short stature.
    Jeong HR; Shim YS; Lee HS; Hwang JS
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):629-33. PubMed ID: 24810558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of growth hormone randomized controlled trials in children with idiopathic short stature.
    Deodati A; Peschiaroli E; Cianfarani S
    Horm Res Paediatr; 2011; 76 Suppl 3():40-2. PubMed ID: 21912163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
    Child CJ; Quigley CA; Cutler GB; Moore WV; Wintergerst KA; Ross JL; Rosenfeld RG; Blum WF
    Horm Res Paediatr; 2019; 91(4):241-251. PubMed ID: 31185471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 4-Year, Open-Label, Multicenter, Randomized Trial of Genotropin® Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-Driven Regimen and Standard Dosing.
    Counts DR; Silverman LA; Rajicic N; Geffner ME; Newfield RS; Thornton P; Carakushansky M; Escobar O; Rapaport R; Levitsky L; Rotenstein D; Hey-Hadavi J; Wajnrajch MP
    Horm Res Paediatr; 2015; 84(2):79-87. PubMed ID: 25966824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
    J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-1 and growth response to adult height in a randomized GH treatment trial in short non-GH-deficient children.
    Kriström B; Lundberg E; Jonsson B; Albertsson-Wikland K;
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2917-24. PubMed ID: 24823461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial.
    Kim J; Suh BK; Ko CW; Lee KH; Shin CH; Hwang JS; Kim HS; Chung WY; Kim CJ; Han HS; Kwon NY; Cho SY; Yoo HW; Jin DK
    J Endocrinol Invest; 2018 Apr; 41(4):475-483. PubMed ID: 29103133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Height gain at adult-height age in 184 short patients treated with growth hormone from prepubertal age to near adult-height age is not related to GH secretory status at GH therapy onset.
    Carrascosa A; Audí L; Fernández-Cancio M; Yeste D; Gussinye M; Campos A; Albisu MA; Clemente M; Bel J; Nosás R; Rabanal M; Del Pozo C; Gómez JM; Mesa J;
    Horm Res Paediatr; 2013; 79():145-56. PubMed ID: 23548791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone use in the treatment of idiopathic short stature.
    Zucchini S
    Curr Opin Investig Drugs; 2008 Apr; 9(4):396-401. PubMed ID: 18393106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis.
    Finkelstein BS; Imperiale TF; Speroff T; Marrero U; Radcliffe DJ; Cuttler L
    Arch Pediatr Adolesc Med; 2002 Mar; 156(3):230-40. PubMed ID: 11876666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting bone age maturation during 3 years of growth hormone treatment in patients with idiopathic growth hormone deficiency and idiopathic short stature: Analysis of data from the LG growth study.
    Kang MJ; Kim EY; Shim YS; Jeong HR; Lee HJ; Yang S; Hwang IT
    Medicine (Baltimore); 2019 Apr; 98(14):e14962. PubMed ID: 30946320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The basis for optimising growth with growth hormone usage in children with idiopathic short stature: analysis of data from KIGS (Pfizer International Growth Study Database).
    Ranke MB; Lindberg A
    Horm Res Paediatr; 2011; 76 Suppl 3():48-50. PubMed ID: 21912166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of different definitions of growth response in short prepubertal children treated with growth hormone.
    Bang P; Bjerknes R; Dahlgren J; Dunkel L; Gustafsson J; Juul A; Kriström B; Tapanainen P; Aberg V
    Horm Res Paediatr; 2011; 75(5):335-45. PubMed ID: 21228552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.